About iDNA Genomics Public Ltd

Company Description

Our company operates in the booming industry of Precision Medicine and Genetic Analysis. Our focus is on developing and providing genetic analysis for Pharmacogenetics. Preventive Medicine and Genomics of Nutrition and Sports, with constant research activity through co-operation with universities in Greece and abroad.

We specialise in Genetics and fully exploit cutting-edge scientific knowledge, to provide innovative DNA analysis services that allow everybody to access their unique genetic traits, with a personalised approach.

We develop innovative and pioneering solutions by leveraging our multidimensional expertise, our scientific staff and Research & Development (R&D) department, the certified laboratories and privately owned bioinformatics analysis platform, a state-of-the-art technology and the collaboration with prestigious Universities and Research Organisations.

Year founded

2020

Served area

Cyprus

Headquarters

6 Theotokis Street, 3rd Floor, 1055 Nicosia – Cyprus

Shareholder information

Shares outstanding

2,600,000

IPO

Dec. 17, 2021

Stock exchange(s)

Cyprus Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.